Acceptance of the CP950 Sound Processor

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acceptance of CP950 sound processor with experienced CP810/CP910/CP920 BTE sound processor users.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Usability of the CP950 Sound Processor

NCT02727842

Hearing Loss

COMPLETED NA

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients

NCT05619575

Hearing Impairment

COMPLETED NA

Investigation of an Updated Bone-anchored Sound Processor

NCT05086809

Hearing Loss Hearing Loss, Conductive Hearing Loss, Mixed +7 more

COMPLETED NA

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

NCT05286385

Hearing Impairment, Sensorineural

COMPLETED NA

Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors

NCT05356221

Hearing Loss Hearing Loss, Conductive Hearing Loss, Unilateral

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss, Sensorineural

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Repeated measures, single-subject experiment. Each subject received the same treatment.

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All participants

At least 6 months experience with a Nucleus 24 series or later implant in at least one implanted ear and at least 3 months experience with the CP810,CP920 or CP910 sound processor.

Group Type EXPERIMENTAL

CP950 OTE Sound processor

Intervention Type DEVICE

CP950 is Off The Ear (OTE) Cochlear Implant Sound Processor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CP950 OTE Sound processor

CP950 is Off The Ear (OTE) Cochlear Implant Sound Processor

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Eighteen years of age or older
2. At least 6 months experience with a Nucleus 24 series or later implant in at least one implanted ear
3. At least 3 months experience with the CP810,CP920 or CP910 sound processor
4. Native speaker in the language used to assess speech perception performance
5. Willingness to participate in and to comply with all requirements of the protocol
6. Able to score 30% or more at +15 SNR with CI alone

Exclusion Criteria

1. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device
2. Additional disabilities that would prevent participation in evaluations
3. Nucleus 22 Implant

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No